kari Therapeutics announced the appointment of Mark Kubik as Head of Business Development – Oncology.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AKTX:
- Akari Therapeutics releases video from newly appointed CEO Gaslightwala
- Akari Therapeutics Advances ADC Development Amid Financial Challenges
- Akari Therapeutics reports FY24 EPS 0c vs 0c last year
- Akari Therapeutics Delays Yearly Financial Report
- Akari Therapeutics Appoints New CEO Abizer Gaslightwala
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue